Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded Healthcare sector company. As of July 22, 2026, CLDI trades at $0.11 with a market cap of $1.92M and a P/E ratio of -0.02. CLDI moved +8.04% today. Year to date, CLDI is -91.50%; over the trailing twelve months it is -98.84%. Its 52-week range spans $0.10 to $26.76. Rallies surfaces CLDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CLDI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.11 |
| Market Cap | $1.92M |
| P/E Ratio | -0.02 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.76 |
| 52-Week Low | $0.10 |
| Volume | 2.70M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-20.06M |
| Gross Margin | 0.00% |
CLDI analyst coverage data. Average price target: $0.00.